Skip to main content

Table 4 Design matrix and response for 23 factorial design batches [X1—drug to span 60 molar ratio, X2—volume of hydration (PBS 7.4), X3—stirring speed, Y1—average vesicle size (nm), and Y2—entrapment efficient (%)]

From: Gamma oryzanol niosomal gel for skin cancer: formulation and optimization using quality by design (QbD) approach

Batch no.

Independent variables in coded form

X1

X2

X3

Y1

Y2

B1

− 1

− 1

− 1

240.0 ± 1.1

60.5 ± 1.1

B2

+ 1

− 1

− 1

208.6 ± 0.9

59.1 ± 3.1

B3

− 1

+ 1

− 1

315.0 ± 2.1

61.4 ± 0.9

B4

+ 1

+ 1

− 1

340.7 ± 2.9

64.9 ± 0.3

B5

− 1

− 1

+ 1

65.1 ± 0.6

55.3 ± 0.5

B6

+ 1

− 1

+ 1

45.0 ± 0.6

48.3 ± 0.8

B7

− 1

+ 1

+ 1

150.6 ± 1.5

84.6 ± 1.9

B8

+ 1

+ 1

+ 1

179.4 ± 1.9

88.5 ± 1.6

B9

0

0

0

105.8 ± 1.2

70.8 ± 2.5

B10

0

0

0

115.5 ± 1.1

72.1 ± 1.7

B11

0

0

0

110.0 ± 0.8

70.9 ± 1.4

B12 (checkpoint batch)

− 0.5

− 0.5

− 0.5

190.7 ± 1.1

65.6 ± 1.8

B13 (optimized batch)

− 0.5

+ 1

+ 1

196.6 ± 0.9

78.31 ± 1.4